Shayla Sharmine

  • ORCID:
  • Researcher ID:
  • Scopus:
  • Google Scholar:
  • Research Gate:

SCIENTIFIC CAREER


Since 2021

PhD candidate at Center for Diabetes Research, Department of Clinical Science, Faculty of Medicine, University of Bergen, Norway

2018 – 2021 Master in Molecular Biology, Faculty of Mathematics and Natural Science, University of Bergen.

2016 – 2018 Master’s in Criminology and Criminal justice, University of Dhaka, Bangladesh.

2011 – 2016 Bachelor of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, Bangladesh.


PUBLICATIONS while in the lab


  1. Unger L, Larsen U, Sharmine S, Hossain MK, Legøy TA, Vaudel M, Ghila L, Chera S. SAM: A FIJI-Based Tool for Semi-Automated Quantification of Cytoplasmic Expression in Cells preprint doi: 10.21203/rs.3.rs-6466373/v1
  2. Sharmine S, Ghila L.Targeting Inflammation in Type 2 Diabetes: The Emerging Role of Decorin. Acta Physiol (Oxf). 2025 Jun;241(6):e70049 doi: 10.1111/apha.70049

ORAL presentations


  • Shayla Sharmine, Thomas Aga Legøy, Andreas Mathisen, Luiza Ghila, Simona Chera. “Mapping the impact of high fat diet challenge in a HNF1A-MODY mouse modelEASD Annual Meeting 2023, 2-6 October 2023 Hamburg, Germany

POSTER presentations


  • Shayla Sharmine,  Luiza Ghila, Simona Chera. Short-term effect of Somatostatin Modulators on Glycemic Control in MODY mice. The Nordic Developmental Biology Societies & Michael Sars Symposium Joint Meeting, 28-31 May 2024, Bergen, Norway
  • Shayla Sharmine, Luiza Ghila, Simona Chera. High Fat Diet challenge in HNF1A MODY mouse model. NorDoc Summer School 16-18 August 2023, Uppsala & Stockholm
  • Shayla Sharmine, Thomas Aga Legøy, Andreas Mathisen, Luiza Ghila, Simona Chera. “Mapping islet architecture changes upon high fat diet challenge in a HNF1A-MODY mouse model”. Diabetesforum 2023, 25-27 April 2023, Oslo, Norway

Journal Club Posts


  1. Chronic intermittent fasting impairs b cell maturation and function in adolescent mice
  2. Paracrine signalling by pancreatic δ cells determines the glycaemic set point in mice
  3. Real time somatostatin detection assay reveals somatostatin hypersecretion in T2D patient derived single islets